RIVA ALENDRONATE DIN 02270870
Status: Cancelled Pre Market
Holder: LABORATOIRE RIVA INC.
Health Canada record
| Active ingredient(s) | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 40 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M05BA04 ALENDRONIC ACID |
| Original market date | |
| Current status date | 01-Sep-2016 |
| Source | Health Canada DPD |
Establishment licence of the holder
Laboratoire Riva Inc. — licence 100179, currently licensed, last inspection rating C (2026-01-12).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02314940 | FOSAVANCE | ORGANON CANADA INC. | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG; VITAMIN D3 (VITAMIN D3) 5600 UNIT | Marketed |
| 02276429 | FOSAVANCE | ORGANON CANADA INC. | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG; VITAMIN D3 (VITAMIN D3) 2800 UNIT | Marketed |
| 02519836 | JAMP ALENDRONATE / VITAMIN D3 | JAMP PHARMA CORPORATION | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG; VITAMIN D3 5600 UNIT | Marketed |
| 02519828 | JAMP ALENDRONATE / VITAMIN D3 | JAMP PHARMA CORPORATION | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG; VITAMIN D3 2800 UNIT | Marketed |
| 02258102 | ACT ALENDRONATE | ACTAVIS PHARMA COMPANY | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 40 MG | Cancelled Post Market |
| 02258110 | ACT ALENDRONATE | ACTAVIS PHARMA COMPANY | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG | Cancelled Post Market |
| 02343916 | ALENDRONATE | COBALT PHARMACEUTICALS COMPANY | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 40 MG | Cancelled Pre Market |
| 02343924 | ALENDRONATE | COBALT PHARMACEUTICALS COMPANY | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG | Cancelled Pre Market |
| 02405717 | ALENDRONATE-CHOLECALCIFEROL | FROSST A DIVISION OF MERCK CANADA INC | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG; VITAMIN D3 (VITAMIN D3) 2800 UNIT | Cancelled Pre Market |
| 02405725 | ALENDRONATE-CHOLECALCIFEROL | FROSST A DIVISION OF MERCK CANADA INC | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG; VITAMIN D3 (VITAMIN D3) 5600 UNIT | Cancelled Pre Market |
| 02248625 | FOSAMAX | MERCK CANADA INC | Solution | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG | Cancelled Post Market |
| 02270110 | GEN-ALENDRONATE | GENPHARM ULC | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 5 MG | Cancelled Post Market |
| 02270129 | MYLAN-ALENDRONATE | MYLAN PHARMACEUTICALS ULC | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 10 MG | Cancelled Post Market |
| 02286335 | MYLAN-ALENDRONATE | MYLAN PHARMACEUTICALS ULC | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG | Cancelled Post Market |
| 02372304 | Q-ALENDRONATE | QD PHARMACEUTICALS ULC | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG | Cancelled Post Market |
| 02429160 | SANDOZ ALENDRONATE/CHOLECALCIFEROL | SANDOZ CANADA INCORPORATED | Tablet | ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70 MG; VITAMIN D3 (VITAMIN D3) 5600 UNIT | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 7358 | 2005-09-09 | Abbreviated New Drug Submission (ANDS) | NEW MANUFACTURER AND PRODUCT NAME |